TABLE 1.
Demographic, Neurological Characteristics and Outcome of the 17 Patients With BD With Refractory Neurological Involvement Treated With Anti-TNFα Antibodies
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.